@article {1633,
	title = {The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL.},
	journal = {Invest New Drugs},
	volume = {30},
	year = {2012},
	month = {2012 Apr},
	pages = {810-8},
	keywords = {Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Apoptosis, Carcinoma, Squamous Cell, Female, Flow Cytometry, HL-60 Cells, Humans, Immunohistochemistry, Male, Middle Aged, Mouth Neoplasms, Predictive Value of Tests, Prognosis, Proportional Hazards Models, Recombinant Proteins, Risk Assessment, Risk Factors, Survival Analysis, TNF-Related Apoptosis-Inducing Ligand, Tumor Markers, Biological, Up-Regulation, Young Adult},
	issn = {1573-0646},
	doi = {10.1007/s10637-010-9586-0},
	author = {Carinci, Francesco and Monasta, Lorenzo and Rubini, Corrado and Stramazzotti, Daniela and Palmieri, Annalisa and Melloni, Elisabetta and Knowles, Alex and Ronfani, Luca and Zauli, Giorgio and Secchiero, Paola}
}
